
TY  - JOUR
TI  - E-Poster Presentations (Oral) | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.14879
DO  - doi:10.1111/jgh.14879
SP  - 72
EP  - 582
PY  - 2019
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology, SIOP XXXVI Congress Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 43
IS  - 4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.20119
DO  - doi:10.1002/pbc.20119
SP  - 305
EP  - 503
PY  - 2004
ER  - 

TY  - JOUR
TI  - Plenary session (ACR)
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 43
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.1780432008
DO  - doi:10.1002/art.1780432008
SP  - S115
EP  - S408
PY  - 2000
ER  - 

TY  - JOUR
TI  - P1198 - P1459
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1430.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1430.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - SCIENTIFIC ABSTRACTS
JO  - Journal of General Internal Medicine
VL  - 21
IS  - S4
SN  - 0884-8734
UR  - https://doi.org/10.1111/j.1525-1497.2006.00469.x
DO  - doi:10.1111/j.1525-1497.2006.00469.x
SP  - 1
EP  - 283
PY  - 2006
ER  - 

TY  - JOUR
TI  - PODIUM SESSIONS
JO  - The Journal of Sexual Medicine
VL  - 6
IS  - s5
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2009.01608_1.x
DO  - doi:10.1111/j.1743-6109.2009.01608_1.x
SP  - 403
EP  - 420
PY  - 2009
ER  - 

TY  - JOUR
TI  - Annual Scientific Meeting of the British Association of Oral Surgeons, London 2011
JO  - Oral Surgery
VL  - 5
IS  - 2
SN  - 1752-2471
UR  - https://doi.org/10.1111/j.1752-248X.2012.01154.x
DO  - doi:10.1111/j.1752-248X.2012.01154.x
SP  - 84
EP  - 107
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts – Posters
JO  - Alcoholism: Clinical and Experimental Research
VL  - 34
IS  - s3
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2010.01292_4.x
DO  - doi:10.1111/j.1530-0277.2010.01292_4.x
SP  - 89A
EP  - 170A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 9 September
JO  - European Journal of Neurology
VL  - 19
IS  - s1
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2012.03888.x
DO  - doi:10.1111/j.1468-1331.2012.03888.x
SP  - 90
EP  - 457
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Tropical Medicine & International Health
JA  - Trop Med Int Health
VL  - 22
IS  - S1
SN  - 1360-2276
UR  - https://doi.org/10.1111/tmi.12979
DO  - doi:10.1111/tmi.12979
SP  - 115
EP  - 345
PY  - 2017
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATIONS
JO  - The Journal of Sexual Medicine
VL  - 6
IS  - s5
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2009.01608_3.x
DO  - doi:10.1111/j.1743-6109.2009.01608_3.x
SP  - 429
EP  - 479
PY  - 2009
ER  - 

TY  - JOUR
TI  - Paper Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 54
IS  - S4
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2006.00783.x
DO  - doi:10.1111/j.1532-5415.2006.00783.x
SP  - S1
EP  - S203
PY  - 2006
ER  - 

TY  - JOUR
TI  - MODERATED POSTER SESSION ABSTRACTS
JO  - The Journal of Sexual Medicine
VL  - 3
IS  - s3
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2006.00188_3.x
DO  - doi:10.1111/j.1743-6109.2006.00188_3.x
SP  - 199
EP  - 223
PY  - 2006
ER  - 

TY  - JOUR
AU  - Gey, A.
AU  - Tadie, J.-M.
AU  - Caumont-Prim, A.
AU  - Hauw-Berlemont, C.
AU  - Cynober, L.
AU  - Fagon, J.-Y.
AU  - Terme, M
AU  - Diehl, J.-L.
AU  - Delclaux, C.
AU  - Tartour, E.
TI  - Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients
JO  - Clinical & Experimental Immunology
JA  - Clin Exp Immunol
VL  - 180
IS  - 2
SN  - 0009-9104
UR  - https://doi.org/10.1111/cei.12567
DO  - doi:10.1111/cei.12567
SP  - 280
EP  - 288
KW  - arginine
KW  - biomarker
KW  - critically ill patients
KW  - granulocytic myeloid-derived suppressor cells (gMDSC)
KW  - immunosuppression
PY  - 2015
AB  - Summary Critically ill patients display a state of immunosuppression that has been attributed in part to decreased plasma arginine concentrations. However, we and other authors have failed to demonstrate a clinical benefit of L-arginine supplementation. We hypothesize that, in these critically ill patients, these low plasma arginine levels may be secondary to the presence of granulocytic myeloid-derived suppressor cells (gMDSC), which express arginase known to convert arginine into nitric oxide (NO) and citrulline. Indeed, in a series of 28 non-surgical critically ill patients, we showed a dramatic increase in gMDSC compared to healthy subjects (P?=?0·0002). A significant inverse correlation was observed between arginine levels and gMDSC (P?=?0·01). As expected, gMDSC expressed arginase preferentially in these patients. Patients with high gMDSC levels on admission to the medical intensive care unit (MICU) presented an increased risk of death at day 7 after admission (P?=?0·02). In contrast, neither plasma arginine levels, monocytic MDSC levels nor neutrophil levels were associated with overall survival at day 7. No relationship was found between body mass index (BMI) or simplified acute physiology score (SAPS) score, sequential organ failure assessment (SOFA) score or gMDSC levels, eliminating a possible bias concerning the direct prognostic role of these cells. As gMDSC exert their immunosuppressive activity via multiple mechanisms [production of prostaglandin E2 (PGE2), interleukin (IL)-10, arginase, etc.], it may be more relevant to target these cells, rather than simply supplementing with L-arginine to improve immunosuppression and its clinical consequences observed in critically ill patients.
ER  - 

TY  - JOUR
TI  - HIGHLIGHTED POSTER SESSIONS
JO  - The Journal of Sexual Medicine
VL  - 6
IS  - s5
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2009.01608_2.x
DO  - doi:10.1111/j.1743-6109.2009.01608_2.x
SP  - 421
EP  - 428
PY  - 2009
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - Venice Arrhythmias 2011: October 9-12, 2011—Venice, Italy
JO  - Journal of Cardiovascular Electrophysiology
VL  - 22
IS  - s1
SN  - 1045-3873
UR  - https://doi.org/10.1111/j.1540-8167.2011.02154.x
DO  - doi:10.1111/j.1540-8167.2011.02154.x
SP  - S1
EP  - S172
PY  - 2011
ER  - 

AU  - Babbal
AU  - Adivitiya
AU  - Mohanty, Shilpa
AU  - Khasa, Yogender Pal
C7  - pp. 225-263
TI  - Enzymes as Therapeutic Agents in Human Disease Management
SN  - 9781119460015
UR  - https://doi.org/10.1002/9781119460053.ch10
DO  - doi:10.1002/9781119460053.ch10
SP  - 225-263
KW  - Therapeutic enzymes
KW  - orphan drugs
KW  - immunogenicity
KW  - enzyme replacement therapy
KW  - Food and Drug Administration (FDA)
PY  - 2011
AB  - Abstract This chapter contains sections titled: Introduction Pancreatic Enzymes Oncolytic Enzymes Antidiabetic Enzymes Liver Enzymes Kidney Disorder DNA- and RNA-Based Enzymes Enzymes for the Treatment of Cardiovascular Disorders Lysosomal Storage Disorders Miscellaneous Enzymes Conclusions
ER  - 

TY  - JOUR
TI  - Foot & mouth disease
JO  - Clinical Microbiology and Infection
VL  - 8
IS  - s1
SN  - 9781119460015
UR  - https://doi.org/10.1111/j.1469-0691.2002.tb00013.x
DO  - doi:10.1111/j.1469-0691.2002.tb00013.x
SP  - 1
EP  - 394
PY  - 2002
ER  - 

TY  - JOUR
TI  - Monday, December 7, 2009 Poster Session 3 8:00 a.m.-6:00 p.m.
JO  - Epilepsia
VL  - 50
IS  - s11
SN  - 9781119460015
UR  - https://doi.org/10.1111/j.1528-1167.2009.02377_10.x
DO  - doi:10.1111/j.1528-1167.2009.02377_10.x
SP  - 328
EP  - 482
PY  - 2009
ER  - 
